Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.

Zayed, Dina G; AbdElhamid, Ahmed S; Freag, May S; Elzoghby, Ahmed O

Zayed, Dina G; AbdElhamid, Ahmed S; Freag, May S; Elzoghby, Ahmed O.

Afiliação

Zayed DG; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
AbdElhamid AS; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
Freag MS; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.
Elzoghby AO; Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta, Egypt.

Nanomedicine (Lond) ; 14(3): 225-228, 2019 02.

Article em En | MEDLINE | ID: mdl-30652951

Assuntos

Sistemas de Liberação de Medicamentos/métodos; Neoplasias/diagnóstico por imagem; Pontos Quânticos; Nanomedicina Teranóstica/métodos; Animais; Portadores de Fármacos/química; Humanos; Nanopartículas/química

Palavras-chave

cancer theranostics; drug delivery; inorganic nanoparticles; lipids; nanohybrids; polymers; polysaccharides; proteins; quantum dots; tumor targeting

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistemas de Liberação de Medicamentos / Pontos Quânticos / Nanomedicina Teranóstica / Neoplasias Limite: Animals / Humans Idioma: En Revista: Nanomedicine (Lond) Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google